SLU-PP-332

99% Pure | Made in USA | Multidose

SLU-PP-332 is a small-molecule research compound classified as a potent agonist of estrogen-related receptors (ERRs), including ERRα, ERRβ, and ERRγ. It has attracted significant attention in preclinical research for its ability to activate transcriptional programs associated with exercise adaptation, metabolic regulation, and endurance capacity.

ERRs are orphan nuclear receptors that play a central role in regulating mitochondrial biogenesis, oxidative metabolism, and fatty acid oxidation. SLU-PP-332 activates these receptors to enhance metabolic gene expression, positioning it as a valuable research tool for studying exercise physiology, metabolic disease, and cellular energy dynamics.

Mechanism of Action

SLU-PP-332 functions as an agonist of estrogen-related receptors (ERRα, ERRβ, and ERRγ), binding to and activating these transcription factors to upregulate genes involved in oxidative metabolism and energy homeostasis. This activation results in:

• Increased mitochondrial biogenesis and oxidative phosphorylation
• Enhanced fatty acid oxidation and lipid metabolism
• Upregulation of exercise-responsive gene programs
• Improved cellular energy production and metabolic efficiency

This mechanism positions SLU-PP-332 as a powerful tool in research exploring exercise mimetics, metabolic reprogramming, and endurance enhancement pathways.

Exercise Mimetic & Endurance Research

Preclinical studies have demonstrated that SLU-PP-332 can activate transcriptional programs typically associated with physical exercise, even in the absence of actual physical activity. In animal models:

• Running endurance and time to exhaustion were significantly improved
• Muscle fiber type composition shifted toward fatigue-resistant oxidative fibers
• Exercise-related gene expression was upregulated in skeletal muscle
• Fatigue resistance was enhanced through improved metabolic efficiency

These findings suggest that ERR activation by SLU-PP-332 may replicate key molecular benefits of exercise, making it highly relevant for research into physical performance and muscle physiology.

Metabolic Regulation & Fat Metabolism Research

Research indicates that SLU-PP-332 may influence whole-body metabolic regulation and fat metabolism. In preclinical models:

• Reduced fat mass and improved body composition were observed
• Enhanced lipid oxidation and decreased lipid accumulation in tissues
• Improved metabolic markers associated with energy balance
• Protection against diet-induced obesity and metabolic dysfunction

These findings highlight the compound’s relevance in research focused on obesity, metabolic syndrome, and lipid metabolism regulation.

Key Research Focus Areas:

• ERR agonism and transcriptional regulation of metabolism
• Exercise mimetic pathways and endurance physiology
• Mitochondrial biogenesis and oxidative metabolism
• Fat metabolism, lipid oxidation, and body composition
• Muscle fiber type adaptation and skeletal muscle function
• Metabolic disease and energy homeostasis research

Quality & Compliance:

• ≥99% purity (HPLC & Mass Spectrometry verified)
• Manufactured in the USA
• Third-party tested by independent U.S. laboratories
• Sterile, research-grade formulation
• Multidose format for controlled research applications

Important Notice:

For research purposes only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.